Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer- and Chemotherapy-Induced Anemia
Access this 15-minute, digital activity reviewing the recently published safety and efficacy data from the IRON-CLAD study that assessed the therapeutic potential of intravenous iron therapy in patients with chemotherapy-induced anemia.
Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer- and Chemotherapy-Induced Anemia
Clinical Commentary
This quick, comprehensive video reviews the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and management of adverse events in patients receiving this therapy.
Faculty: Jeffrey Gilreath, PharmD
Release Date:
Expiration Date: April 30, 2023
CME/CE is no longer available for this activity
